pSivida Corp. (NASDAQ: PSDV), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the acquisition ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE